Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Biosynthesis; Chemistry; Mechanisms of Action and Resistance

Inhibition of Influenza Virus Ribonucleic Acid Polymerase by Ribavirin Triphosphate

Bertil Eriksson, Erik Helgstrand, Nils Gunnar Johansson, Alf Larsson, Alfons Misiorny, Jan Olof Noren, Lennart Philipson, Kjell Stenberg, Goran Stening, Stig Stridh, Bo Öberg
Bertil Eriksson
Research and Development Laboratories, Astra Läkemedel AB, Södertälje, and Department of Microbiology, Biomedical Center, University of Uppsala, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik Helgstrand
Research and Development Laboratories, Astra Läkemedel AB, Södertälje, and Department of Microbiology, Biomedical Center, University of Uppsala, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nils Gunnar Johansson
Research and Development Laboratories, Astra Läkemedel AB, Södertälje, and Department of Microbiology, Biomedical Center, University of Uppsala, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alf Larsson
Research and Development Laboratories, Astra Läkemedel AB, Södertälje, and Department of Microbiology, Biomedical Center, University of Uppsala, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfons Misiorny
Research and Development Laboratories, Astra Läkemedel AB, Södertälje, and Department of Microbiology, Biomedical Center, University of Uppsala, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Olof Noren
Research and Development Laboratories, Astra Läkemedel AB, Södertälje, and Department of Microbiology, Biomedical Center, University of Uppsala, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lennart Philipson
Research and Development Laboratories, Astra Läkemedel AB, Södertälje, and Department of Microbiology, Biomedical Center, University of Uppsala, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kjell Stenberg
Research and Development Laboratories, Astra Läkemedel AB, Södertälje, and Department of Microbiology, Biomedical Center, University of Uppsala, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Goran Stening
Research and Development Laboratories, Astra Läkemedel AB, Södertälje, and Department of Microbiology, Biomedical Center, University of Uppsala, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stig Stridh
Research and Development Laboratories, Astra Läkemedel AB, Södertälje, and Department of Microbiology, Biomedical Center, University of Uppsala, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bo Öberg
Research and Development Laboratories, Astra Läkemedel AB, Södertälje, and Department of Microbiology, Biomedical Center, University of Uppsala, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.11.6.946
  • Article
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Ribavirin 5′-triphosphate (RTP), derived from the broad-spectrum antiviral compound ribavirin (Virazole), can selectively inhibit influenza virus ribonucleic acid polymerase in a cell-free assay. Ribavirin and its 5′-monophosphate have no effect on the polymerase. The inhibition is competitive with respect to adenosine 5′-triphosphate and guanosine 5′-triphosphate. RTP also inhibits ApG- and GpC-stimulated influenza virus ribonucleic acid polymerase. Since ribavirin is phosphorylated in the cell, the inhibition of influenza multiplication in the cell may also be caused by RTP.

  • Copyright © 1977 American Society for Microbiology
PreviousNext
Back to top
Download PDF
Citation Tools
Inhibition of Influenza Virus Ribonucleic Acid Polymerase by Ribavirin Triphosphate
Bertil Eriksson, Erik Helgstrand, Nils Gunnar Johansson, Alf Larsson, Alfons Misiorny, Jan Olof Noren, Lennart Philipson, Kjell Stenberg, Goran Stening, Stig Stridh, Bo Öberg
Antimicrobial Agents and Chemotherapy Jun 1977, 11 (6) 946-951; DOI: 10.1128/AAC.11.6.946

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Inhibition of Influenza Virus Ribonucleic Acid Polymerase by Ribavirin Triphosphate
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Inhibition of Influenza Virus Ribonucleic Acid Polymerase by Ribavirin Triphosphate
Bertil Eriksson, Erik Helgstrand, Nils Gunnar Johansson, Alf Larsson, Alfons Misiorny, Jan Olof Noren, Lennart Philipson, Kjell Stenberg, Goran Stening, Stig Stridh, Bo Öberg
Antimicrobial Agents and Chemotherapy Jun 1977, 11 (6) 946-951; DOI: 10.1128/AAC.11.6.946
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596